Drawing for GWPHARM

USPTO serial 79154002

GWPHARM

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
FAIRBANKS, RONALD L
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GWPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle L. Visser

MICHELLE L VISSER RADER FISHMAN & GRAUER PLLC39533 WOODWARD AVESTE 140BLOOMFIELD HILLS, MI 48304

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 21, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 21, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 20, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2016FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 13, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 13, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 13, 2015MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 13, 2015ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 13, 2015OP.TOPPOSITION TERMINATED NO. 999999—
Oct 13, 2015OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 19, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 24, 2015RFNPREFUSAL PROCESSED BY IB—
Mar 23, 2015OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 20, 2015OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Mar 20, 2015OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Mar 19, 2015OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Feb 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2015GPNXNOTIFICATION PROCESSED BY IB—
Jan 28, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 28, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2015ALIEASSIGNED TO LIE—
Jan 12, 2015ALIEASSIGNED TO LIE—
Jan 12, 2015ALIEASSIGNED TO LIE—
Dec 21, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 22, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 22, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 8, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 6, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 6, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 5, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 4, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2014DOCKASSIGNED TO EXAMINER—
Nov 4, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance